Ki-67 expression rates as indicator of metastatic lesions in lung neuroendocrine neoplasmsAuthor:Chytaieva H. Т. 12, № 3-4 (47-48)
Oncourology. The latest technologies in today’s realities: the results of the PROfound study — the efficacy and safety profile of olaparib in mCRPCТ. 12, № 3-4 (47-48)
